95. Klein WA, Krevsky B, Klepper L, et al. Nonsteroidal antiinflammatory drugs and upper

gastrointestinal hemorrhage in an urban hospital. Dig Dis Sci 1993;38:2049–2055.

96. Lanza FL, Fakouhi D, Rubin A, et al. A double-blind placebo-controlled comparison of the efficacy

and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofeninduced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 1989;84:633–636.

97. Robinson MG, Griffin JW Jr, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal

damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989;34:424–428.

98. Pfaffenbach B, Adamek RJ, Wegener M. Endoscopic band ligation for treatment of postpolypectomy bleeding. Z Gastroenterol 1996;34:241–242.

99. Wilcox CM, Alexander LN, Cotsonis GA, et al. Nonsteroidal antiinflammatory drugs are associated

with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997;42:990–997.

100. Holt S, Rigoglioso V, Sidhu M, et al. Nonsteroidal antiinflammatory drugs and lower

gastrointestinal bleeding. Dig Dis Sci 1993;38:1619–1623.

101. Laine L, Curtis SP, Cryer B, et al. Assessment of upper gastrointestinal safety of etoricoxib and

diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib

and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet

2007;369:465–473.

102. Laine L, Curtis SP, Langman M, et al. Lower gastrointestinal events in a double-blind trial of the

cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory

drug diclofenac. Gastroenterology 2008;135:1517–1525.

103. Rostom A, Muir K, Dubé C, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane

Collaboration systematic review. Clin Gastroenterol Hepatol 2007;5:818–828. e5.

104. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal

Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are

associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004;99:1238–1246.

105. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endoscopy in patients with gastrointestinal

bleeding. N Engl J Med 2007;356:1631–1640.

106. Chan FK. Proton-pump inhibitors in peptic ulcer disease. Lancet 2008;372:1198–1200.

107. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding:

Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82:286–

296.

108. Management of Acute Upper and Lower Gastrointestinal Bleeding: A National Clinical Guideline.

http://wwwsignacuk/pdf/sign105pdf2009

109. Palmer K, Nairn M. Management of acute gastrointestinal blood loss: summary of SIGN guidelines.

BMJ 2008;337:a1832.

110. Dore MP, Graham DY. Ulcers and gastritis. Endoscopy 2004;36:42–47.

111. Vergara M, Casellas F, Saperas E, et al. Helicobacter pylori eradication prevents recurrence from

peptic ulcer haemorrhage. Eur J Gastroenterol Hepatol 2000;12:733–737.

112. Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper

gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997;42:586–591.

113. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974;2:394–

397.

114. Raju GS, Gajula L. Endoclips for GI endoscopy. Gastrointest Endosc 2004; 59:267–279.

115. Naga MI, Okasha HH, Foda AR, et al. Detachable endoloop vs. elastic band ligation for bleeding

esophageal varices. Gastrointest Endosc 2004; 59:804–809.

116. Cappell MS, Friedel D. Acute nonvariceal upper gastrointestinal bleeding: endoscopic diagnosis and

therapy. Med Clin North Am 2008;92:511-viii.

117. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo-coagulation in the

treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007;56:1364–1373.

118. Asaki S. Endoscopic Haemostasis by Local Absolute Alcohol Injection for UGI Tract Bleeding: a

Multicentre Study. Endoscopic Surgery. New York, NY: Elsevier; 1999:105.

119. Sacks HS, Chalmers TC, Blum AL, et al. Endoscopic hemostasis. An effective therapy for bleeding

peptic ulcers. JAMA 1990;264:494–499.

1704

120. Sugawa C, Steffes CP, Nakamura R, et al. Upper GI bleeding in an urban hospital. Etiology,

recurrence, and prognosis. Ann Surg 1990;212:521–526.

121. Adler DG, Leighton JA, Davila RE, et al. ASGE guideline: the role of endoscopy in acute nonvariceal upper-GI hemorrhage. Gastrointest Endosc 2004;60:497–504.

122. Loren A. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a metaanalysis. Gastroenterology 1992;102:139–148.

123. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with

recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999;340:751–

756.

124. Gupta PK, Fleischer DE. Nonvariceal upper gastrointestinal bleeding. Med Clin North Am

1993;77:973–992.

125. Teenan RP, Murray WR. Late outcome of undersewing alone for gastric ulcer haemorrhage. Br J

Surg 1990;77:811–812.

126. Reuben BC, Stoddard G, Glasgow R, et al. Trends and predictors for vagotomy when performing

oversew of acute bleeding duodenal ulcer in the United States. J Gastrointest Surg 2007;11:22–28.

127. Schroder VT, Pappas TN, Vaslef SN, et al. Vagotomy/drainage is superior to local oversew in

patients who require emergency surgery for bleeding peptic ulcers. Ann Surg 2014;259:1111–1118.

128. Poultsides GA, Kim CJ, Orlando R III, et al. Angiographic embolization for gastroduodenal

hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg 2008;143:457–461.

129. Loffroy R, Rao P, Ota S, et al. Embolization of acute nonvariceal upper gastrointestinal hemorrhage

resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Interv

Radiol 2010;33:1088–1100.

130. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill

patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377–381.

131. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit

patients. J Crit Care 2005;20:35–45.

132. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate

as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J

Med 1987;317:1376–1382.

133. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of

upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care

Trials Group. N Engl J Med 1998;338:791–797.

134. Athanasoulis CA. Therapeutic applications of angiography (first of two parts). N Engl J Med

1980;302:1117–1125.

135. Robert A, Kauffman G. Stress ulcers, erosions, and gastric mucosal injury. In: Sleisinger M, Fordtran

J, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 4th ed. Philadelphia, PA:

Saunders; 1989:772–792.

136. Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady

Hospital experience. South Med J 1999;92:44–50.

137. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus

workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762–

768.

138. Jenkins SA, Baxter JN, Critchley M, et al. Randomised trial of octreotide for long term

management of cirrhosis after variceal haemorrhage. BMJ 1997;315:1338–1341.

139. Imperiale TF, Teran JC, McCullough AJ. A meta-analysis of somatostatin versus vasopressin in the

management of acute esophageal variceal hemorrhage. Gastroenterology 1995;109:1289–1294.

140. Burroughs AK. Octreotide in variceal bleeding. Gut 1994;35:S23–S27.

141. Avgerinos A, Nevens F, Raptis S, et al. Early administration of somatostatin and efficacy of

sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal

Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350:1495–1499.

142. Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal

bleeding. N Engl J Med 1995;333:555–560.

143. Hermann RE, Traul D. Experience with the Sengstaken-Blakemore tube for bleeding esophageal

varices. Surg Gynecol Obstet 1970;130:879–885.

1705

144. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its

early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology

2004;40:793–801.

145. Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval

shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.

J Am Coll Surg 1995; 180:257–272.

146. Papatheodoridis GV, Goulis J, Leandro G, et al. Transjugular intrahepatic portosystemic shunt

compared with endoscopic treatment for prevention of variceal rebleeding: A meta analysis.

Hepatology 1999;30:612–622.

147. Mallory GK, Weiss S. Hemorrhages from lacerations of the cardiac orifice of the stomach due to

vomiting. Am J Med Sci 1929;178:506–515.

148. Silverstein FE, Gilbert DA, Tedesco FJ, et al. The national ASGE survey on upper gastrointestinal

bleeding. II. Clinical prognostic factors. Gastrointest Endosc 1981;27:80–93.

149. Park CH, Min SW, Sohn YH, et al. A prospective, randomized trial of endoscopic band ligation vs.

epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc

2004;60:22–27.

150. McGuire HH Jr, Haynes BW Jr. Massive hemorrhage for diverticulosis of the colon: guidelines for

therapy based on bleeding patterns observed in fifty cases. Ann Surg 1972;175:847–855.

151. McGuire HH Jr. Bleeding colonic diverticula. A reappraisal of natural history and management. Ann

Surg 1994;220:653–656.

152. Casarella WJ, Kanter IE, Seaman WB. Right-sided colonic diverticula as a cause of acute rectal

hemorrhage. N Engl J Med 1972;286:450–453.

153. Niikura R, Nagata N, Yamada A, et al. Recurrence of colonic diverticular bleeding and associated

risk factors. Colorectal Dis 2012;14:302–305.

154. Okamoto T, Watabe H, Yamada A, et al. The association between arteriosclerosis related diseases

and diverticular bleeding. Int J Colorectal Dis 2012;27:1161–1166.

155. Boley SJ, DiBiase A, Brandt LJ, et al. Lower intestinal bleeding in the elderly. Am J Surg

1979;137:57–64.

156. Kuo WT, Lee DE, Saad WE, et al. Superselective microcoil embolization for the treatment of lower

gastrointestinal hemorrhage. J Vasc Interv Radiol 2003;14:1503–1509.

157. Gady JS, Reynolds H, Blum A. Selective arterial embolization for control of lower gastrointestinal

bleeding: recommendations for a clinical management pathway. Curr Surg 2003;60:344–347.

158. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807–818.

159. Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among

healthy asymptomatic people. Am J Gastroenterol 1995;90:564–567.

160. Sharma R, Gorbien MJ. Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients.

Arch Intern Med 1995;155:807–812.

161. Richter JM, Hedberg SE, Athanasoulis CA, et al. Angiodysplasia. Clinical presentation and

colonoscopic diagnosis. Dig Dis Sci 1984;29:481–485.

162. Gupta N, Longo WE, Vernava AM. Angiodysplasia of the lower gastrointestinal tract: an entity

readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum

1995;38:979–982.

163. Bemvenuti GA, Julich MM. Ethanolamine injection for sclerotherapy of angiodysplasia of the colon.

Endoscopy 1998;30:564–569.

164. Junquera F, Feu F, Papo M, et al. A multicenter, randomized, clinical trial of hormonal therapy in

the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001;121:1073–

1079.

165. Bauditz J, Lochs H. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment

of gastrointestinal bleeding. World J Gastroenterol 2007;13:5979–5984.

166. Dabak V, Kuriakose P, Kamboj G, et al. A pilot study of thalidomide in recurrent GI bleeding due to

angiodysplasias. Dig Dis Sci 2008;53:1632–1635.

167. Szilagyi A, Ghali MP. Pharmacological therapy of vascular malformations of the gastrointestinal

tract. Can J Gastroenterol 2006;20:171.

1706